These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35737669)

  • 1. Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR.
    Yu Z; Li M; Wang K; Gu Y; Guo S; Wang W; Ma Y; Liu H; Chen Y
    J Med Chem; 2022 Jul; 65(13):9328-9349. PubMed ID: 35737669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents.
    Guo Y; Wang Y; Li H; Wang K; Wan Q; Li J; Zhou Y; Chen Y
    ACS Med Chem Lett; 2018 May; 9(5):502-506. PubMed ID: 29795767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.
    Liu MM; Chen XY; Huang YQ; Feng P; Guo YL; Yang G; Chen Y
    J Med Chem; 2014 Nov; 57(22):9343-56. PubMed ID: 25350923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
    Li H; Wang K; Wan Q; Chen Y
    Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.
    Hong W; Shi H; Qiao M; Gao X; Yang J; Tian C; Zhang D; Niu S; Liu M
    Int J Nanomedicine; 2017; 12():989-1007. PubMed ID: 28243082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
    Zhong H; Zhao M; Wu C; Zhang J; Chen L; Sun J
    Eur J Med Chem; 2022 May; 235():114300. PubMed ID: 35339100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
    Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
    Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
    Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].
    Cheng YH; Qi J; Xiong DS; Liu JW; Qi SL; Pan B; Yang CZ; Zhu HF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):164-8. PubMed ID: 16733896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
    Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
    Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling.
    Yang X; Ding Y; Xiao M; Liu X; Ruan J; Xue P
    Chem Biol Interact; 2017 Dec; 278():22-31. PubMed ID: 28987325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhancement of FG020326 on sensitivity of MCF-7/ADR cells to taxotere via enhancing activation of caspase-8 and caspase-3].
    Wang XW; Ding Y; Liang YJ; Chen LM; Shi Z; Yang XP; Gu LQ; Fu LW
    Ai Zheng; 2004 Nov; 23(11 Suppl):1379-85. PubMed ID: 15566641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
    De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
    Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.
    Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P
    Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R; Li W; Zhang X; Zhang Y; Peng H; Xie Y; Fan D; Liu R; Liu X; Xiong D
    Eur J Pharmacol; 2011 Nov; 669(1-3):38-44. PubMed ID: 21871878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.